281 related articles for article (PubMed ID: 2850460)
21. Effect of rate of calcium reduction and a hypocalcemic clamp on parathyroid hormone secretion: a study in dogs.
Estepa JC; Aguilera-Tejero E; Almaden Y; Rodriguez M; Felsenfeld AJ
Kidney Int; 1999 May; 55(5):1724-33. PubMed ID: 10231434
[TBL] [Abstract][Full Text] [Related]
22. Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism.
Caravaca F; Cubero JJ; Jimenez F; López JM; Aparicio A; Cid MC; Pizarro JL; Liso J; Santos I
Nephrol Dial Transplant; 1995; 10(5):665-70. PubMed ID: 7566580
[TBL] [Abstract][Full Text] [Related]
23. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
24. Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia.
Rajala MM; Klee GG; Heath H
J Bone Miner Res; 1991 Feb; 6(2):117-24. PubMed ID: 2028833
[TBL] [Abstract][Full Text] [Related]
25. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
[TBL] [Abstract][Full Text] [Related]
26. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism.
Insogna KL; Mitnick ME; Stewart AF; Burtis WJ; Mallette LE; Broadus AE
N Engl J Med; 1985 Oct; 313(18):1126-30. PubMed ID: 2995810
[TBL] [Abstract][Full Text] [Related]
28. Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism.
Heath H; Purnell DC
J Lab Clin Med; 1980 Dec; 96(6):974-84. PubMed ID: 6253580
[TBL] [Abstract][Full Text] [Related]
29. Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.
Lambert PW; Heath H; Sizemore GW
J Clin Invest; 1979 Apr; 63(4):602-8. PubMed ID: 438324
[TBL] [Abstract][Full Text] [Related]
30. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H
J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032
[TBL] [Abstract][Full Text] [Related]
31. Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients.
Dumoulin G; Hory B; Nguyen NU; Henriet MT; Bresson C; Regnard J; Saint-Hillier Y
Am J Nephrol; 1995; 15(3):238-44. PubMed ID: 7618649
[TBL] [Abstract][Full Text] [Related]
32. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP
J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621
[TBL] [Abstract][Full Text] [Related]
33. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
[TBL] [Abstract][Full Text] [Related]
34. Determinants of parathormone secretion in primary hyperparathyroidism.
Paillard M; Gardin JP; Borensztein P; Prigent A
Horm Res; 1989; 32(1-3):89-92. PubMed ID: 2693319
[TBL] [Abstract][Full Text] [Related]
35. Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia.
Vantini I; Cominacini L; Ederle A; Galvanini G; Piubello W; Adami S; Cavallini G; Lo Cascio V
Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):472-7. PubMed ID: 549429
[TBL] [Abstract][Full Text] [Related]
36. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
38. Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism.
Marx SJ; Lasker RD; Brown EM; Fitzpatrick LA; Sweezey NB; Goldbloom RB; Gillis DA; Cole DE
J Clin Endocrinol Metab; 1986 Feb; 62(2):445-9. PubMed ID: 3941166
[TBL] [Abstract][Full Text] [Related]
39. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
Madvig P; Young G; Marcus R
J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
[TBL] [Abstract][Full Text] [Related]
40. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
Broadus AE; Deftos LJ; Bartter FC
J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]